Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rothstein

Showing results (371-380 of 432) with videos related to

Pageof 44
Sort By:
Elife|April 2, 2024
Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitisKyounghee Min, Batuhan Yenilmez, Mark Kelly, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitisKyounghee Min, Batuhan Yenilmez, Mark Kelly, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Mutant SOD1 expressed by oligodendrocytes aggregates in myelinic nanochannels and accelerates disease progression in familial ALS miceAlexandra I Mot, Ying Li, Payam Dibaj, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementiaTao Zu, Yuanjing Liu, Monica Bañez-Coronel, et al.
Nature Communications|August 14, 2025
Biobank-scale genetic characterization of Alzheimer's disease and related dementias across diverse ancestriesMarzieh Khani, Fulya Akçimen, Spencer M Grant, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Biobank-scale characterization of Alzheimer's disease and related dementias identifies potential disease-causing variants, risk factors, and genetic modifiers across diverse ancestriesMarzieh Khani, Fulya Akçimen, Spencer M Grant, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
Wild-type <i>C9orf72</i> expression is a genetic modifier of C9-ALS survivalStanislav Tsitkov, Akshay Raju, Jie Wu, et al.
Nature|January 7, 2005
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expressionJeffrey D Rothstein, Sarjubhai Patel, Melissa R Regan, et al.
Muscle & Nerve|May 24, 2020
Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunitiesJinsy A Andrews, James D Berry, Robert H Baloh, et al.
Neuron|July 6, 2004
Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondriaJian Liu, Concepción Lillo, P Andreas Jonsson, et al.
Pageof 44

Showing results (371-380 of 432) with videos related to

Sort By:
Pageof 44
Elife|April 2, 2024
Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitisKyounghee Min, Batuhan Yenilmez, Mark Kelly, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitisKyounghee Min, Batuhan Yenilmez, Mark Kelly, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Mutant SOD1 expressed by oligodendrocytes aggregates in myelinic nanochannels and accelerates disease progression in familial ALS miceAlexandra I Mot, Ying Li, Payam Dibaj, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementiaTao Zu, Yuanjing Liu, Monica Bañez-Coronel, et al.
Nature Communications|August 14, 2025
Biobank-scale genetic characterization of Alzheimer's disease and related dementias across diverse ancestriesMarzieh Khani, Fulya Akçimen, Spencer M Grant, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Biobank-scale characterization of Alzheimer's disease and related dementias identifies potential disease-causing variants, risk factors, and genetic modifiers across diverse ancestriesMarzieh Khani, Fulya Akçimen, Spencer M Grant, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
Wild-type <i>C9orf72</i> expression is a genetic modifier of C9-ALS survivalStanislav Tsitkov, Akshay Raju, Jie Wu, et al.
Nature|January 7, 2005
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expressionJeffrey D Rothstein, Sarjubhai Patel, Melissa R Regan, et al.
Muscle & Nerve|May 24, 2020
Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunitiesJinsy A Andrews, James D Berry, Robert H Baloh, et al.
Neuron|July 6, 2004
Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondriaJian Liu, Concepción Lillo, P Andreas Jonsson, et al.
Pageof 44